All posts
-
Weekly funding round-up! All of the European startup funding rounds we tracked this week (Jan. 26-30)
Friday is below with a brand-new version of our regular VC financing introduction for our charter member. Listed below you’ll locate today’s introduction of all the (eq…
-
What Series A founders get wrong about hiring
You simply shut your Collection A. The cord struck recently, and currently you’re looking at a working with strategy that asks for tripling your group in eighteen months. The…
-
Not letting context collapse: from Series A growth to Series B readiness
Collection A is usually referred to as a slingshot, but also for several owners it really feels even more like a centrifuge. The centre totters, energy rises, and yet end results c…
-
GuestReady’s acquisition of Lightbooking lifts Spanish portfolio by 200+ units, taking global total beyond 4,000
GuestReady, a Swiss temporary rental monitoring firm, is broadening right into the Canary Islands with the procurement of Lightbooking, a Spanish holiday rental monitoring and circ…
-
UK’s WealthAi closes €837k pre-Seed to automate workflows for private banks and family offices
London-based WealthAi, a FinTech company and the first AI-driven OS designed specifically for wealth managers, family offices and private banks, has raised an initial €837k ($1 mil…
-
Novo Nordisk’s director in China steps down
Christine Zhou, that is the head of the China Area at Novo Nordisk, will certainly tip down at the end of March. A follower has actually been selected.
-
Lundbeck shows strong performance again with best-selling migraine medication in new study
Simply over 75% of clients in a brand-new research study experienced enhancements in their migraine headache, Lundbeck records.
-
Novo Nordisk nears EU approval for MASH drug
Semaglutide is currently authorized to deal with MASH in the United States, however in the EU the therapy seems called Kayshild.
-
Trump’s online pharmacy is central to agreement with Novo Nordisk – launch now postponed
To name a few points, the Trumprx internet site will certainly market Novo Nordisk’s fat burning items straight to American customers. The launch was prepared for January, ye…
-
Danish life science players on China trip after confrontation with the US: “We must seek other avenues”
In spite of Chinese market difficulties, especially for clinical modern technology firms, Ambu, Lundbeck, Novo Nordisk, and Leo Pharma are done in China to enhance teamwork complyi…